Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Ridker PM, Hennekens CH, Buring JE, Rifai N.

N Engl J Med. 2000 Mar 23;342(12):836-43.

2.

C-reactive protein: a new risk assessment tool for cardiovascular disease.

Clearfield MB.

J Am Osteopath Assoc. 2005 Sep;105(9):409-16. Review.

PMID:
16239491
3.

Inflammatory bio-markers and cardiovascular risk prediction.

Blake GJ, Ridker PM.

J Intern Med. 2002 Oct;252(4):283-94. Review.

4.

High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.

Koenig W.

Int J Cardiol. 2013 Oct 15;168(6):5126-34. doi: 10.1016/j.ijcard.2013.07.113. Epub 2013 Aug 24. Review.

PMID:
23978367
6.

Inflammatory biomarkers in coronary artery disease.

Zakynthinos E, Pappa N.

J Cardiol. 2009 Jun;53(3):317-33. doi: 10.1016/j.jjcc.2008.12.007. Epub 2009 Jan 29. Review.

7.

C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians.

Windgassen EB, Funtowicz L, Lunsford TN, Harris LA, Mulvagh SL.

Postgrad Med. 2011 Jan;123(1):114-9. doi: 10.3810/pgm.2011.01.2252. Review.

PMID:
21293091
9.

[The significance of high sensitive C reactive protein as a risk factor for cardiovascular diseases].

Meguro S, Ishibashi M, Takei I.

Rinsho Byori. 2012 Apr;60(4):356-61. Review. Japanese.

PMID:
22686046
10.

C-reactive protein in end-stage renal disease: are there reasons to measure it?

Stenvinkel P, Lindholm B.

Blood Purif. 2005;23(1):72-8. Review.

PMID:
15627740
11.

Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker.

Jialal I, Devaraj S.

Am J Clin Pathol. 2001 Dec;116 Suppl:S108-15. Review.

PMID:
11993695
12.

Inflammatory biomarkers of the patient with myocardial insufficiency.

Blake GJ.

Curr Opin Crit Care. 2003 Oct;9(5):369-74. Review.

PMID:
14508149
13.

The incremental value of lipids and inflammatory biomarkers in determining residual cardiovascular risk.

Mangalmurti SS, Davidson MH.

Curr Atheroscler Rep. 2011 Oct;13(5):373-80. doi: 10.1007/s11883-011-0190-3. Review.

PMID:
21773803
14.

[High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease].

Silva D, Pais de Lacerda A.

Rev Port Cardiol. 2012 Nov;31(11):733-45. doi: 10.1016/j.repc.2012.02.018. Epub 2012 Oct 6. Review. Portuguese.

PMID:
23046630
15.

Prediction of cardiovascular disease events.

Wilson PW.

Cardiol Clin. 2011 Feb;29(1):1-13. doi: 10.1016/j.ccl.2010.10.004. Epub 2010 Dec 17. Review.

PMID:
21257097
16.

Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein.

Dandona P.

Mayo Clin Proc. 2008 Mar;83(3):333-42. doi: 10.4065/83.3.333. Review.

PMID:
18316001
17.

Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses.

van Holten TC, Waanders LF, de Groot PG, Vissers J, Hoefer IE, Pasterkamp G, Prins MW, Roest M.

PLoS One. 2013 Apr 22;8(4):e62080. doi: 10.1371/journal.pone.0062080. Print 2013. Review.

18.

Novel risk factors for atherosclerosis.

Kullo IJ, Gau GT, Tajik AJ.

Mayo Clin Proc. 2000 Apr;75(4):369-80. Review.

PMID:
10761492
19.

C-reactive protein and malignancy: clinico-pathological association and therapeutic implication.

Wang CS, Sun CF.

Chang Gung Med J. 2009 Sep-Oct;32(5):471-82. Review.

20.

Inflammatory markers of cardiovascular disease in the elderly.

Ramos AM, Pellanda LC, Gus I, Portal VL.

Arq Bras Cardiol. 2009 Mar;92(3):221-8, 227-34. Review. English, Spanish.

Supplemental Content

Support Center